Literature DB >> 911608

The disposition of sodium fusidate in man.

R Wise, M Pippard, M Mitchard.   

Abstract

1 In a pharmacokinetic study in six volunteers serum fusidic acid concentrations were obtained after rapid intravenous administration of 100 mg. 2 Analysis of the data suggests that the serum concentration/time curve is biphasic and that the curve can be described by the following equation: cp=5.9e(-1.82t)+4.3e(-0.13t). 3 The disposition characteristics of sodium fusidate have been calculated from this relationship and a plasma half life for sodium fusidate of between 5 and 6 h obtained. 4 Subsequently plasma fusidic acid levels have been measured in the same volunteers on three occasions after sodium fusidate (500 mg) given either as a slow intravenous infusion, or orally as a capsule or as a suspension. 5 Serum levels and AUC after a capsule were about 75% of those obtained after the infusion (30 and 70 mg/1 at peak respectively) whereas levels and AUC after the suspension were only about 50%.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 911608      PMCID: PMC1429160          DOI: 10.1111/j.1365-2125.1977.tb00795.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Fucidin: a new orally active antibiotic.

Authors:  W GODTFREDSEN; K ROHOLT; L TYBRING
Journal:  Lancet       Date:  1962-05-05       Impact factor: 79.321

2.  Fusidic acid: a new antibiotic.

Authors:  W O GODTFREDSEN; S JAHNSEN; H LORCK; K ROHOLT; L TYBRING
Journal:  Nature       Date:  1962-03-10       Impact factor: 49.962

3.  Antibiotic therapy of chronic post-traumatic osteomyelitis.

Authors:  G Hierholzer; J Rehn; H Knothe; J Masterson
Journal:  J Bone Joint Surg Br       Date:  1974-11

4.  Serum levels with sodium fusidate.

Authors:  B A Saggers; H F Harwood; B H Day
Journal:  Br J Clin Pract       Date:  1968-10

5.  Studies on the absorption and tolerance of a new fucidin suspension.

Authors:  J Masterson; L Goldman
Journal:  Ir J Med Sci       Date:  1970-03       Impact factor: 1.568

6.  [Fusidic acid concentrations in chronically inflamed tissue. Studies of chronic posttraumatic osteomyelitis].

Authors:  G Hierholzer; H Knothe; J Rehn; F Koch
Journal:  Arzneimittelforschung       Date:  1966-11

7.  Fucidin in patients on haemodialysis.

Authors:  J A Hobby; L Beeley; J L Whitby
Journal:  J Clin Pathol       Date:  1970-09       Impact factor: 3.411

  7 in total
  5 in total

1.  Susceptibility of mycobacteria to fusidic acid.

Authors:  S E Hoffner; B Olsson-Liljequist; K J Rydgård; S B Svenson; G Källenius
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

2.  Pharmacokinetics of intravenous fusidic acid in patients with cholestasis.

Authors:  J D Peter; F Jehl; T Pottecher; J P Dupeyron; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

3.  Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci.

Authors:  E Toma; D Barriault
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

4.  Antibiotic activity in serum following single and repeated oral administration of sodium fusidate in volunteers.

Authors:  P Munkholm; H Hey; S N Rasmussen; P B Johansen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Oct-Dec       Impact factor: 2.441

5.  Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery.

Authors:  M G Bergeron; D Desaulniers; C Lessard; M Lemieux; J P Després; J Métras; G Raymond; G Brochu
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.